Immunological effects of macrolides

被引：33

作者：

Labro, MT ^{[1
]}

机构：

[1] Ctr Hosp Univ Bichat Claude Bernard, Lab Hematol & Immunol, INSERM, U479, F-75018 Paris, France

来源：

CURRENT OPINION IN INFECTIOUS DISEASES | 1998年 / 11卷 / 06期

关键词：

D O I：

10.1097/00001432-199812000-00006

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Various reviews have highlighted the potential immunomodulating properties of macrolides, Recent data in this field raise the possibility of new therapeutic prospects in cancer and inflammatory diseases (cystic fibrosis, asthma, atherosclerosis, etc.). Advances have also been made in our understanding of the interactions between macrolides and host immune effecters, particularly phagocytes, The third millenium should see exciting new uses of macrolides. Curr Opin infect Dis 11:681-688. (C) 1998 Lippincott Williams & Wilkins.

引用

页码：681 / 688

页数：8

共 47 条

[1] Abdelghaffar H, 1997, J IMMUNOL, V159, P3995
[2] ABDELGHAFFAR H, 1996, 36 INT C ANT AG CHEM
[3] ANDES D, 1998, 4 INT C MACR AZ STRE
[4] ARAYSSI T, 1998, 4 INT C MACR AZ STRE
[5] Pharmacokinetics of oral azithromycin in serum, urine, polymorphonuclear leucocytes and inflammatory vs non-inflammatory skin blisters in healthy volunteers
Ballow, CH
Amsden, GW
Highet, VS
Forrest, A
[J]. CLINICAL DRUG INVESTIGATION, 1998, 15 (02) : 159 - 167
[6] BERMUDEZ LE, 1998, 4 INT C MACR AZ STRE
[7] BISCIONE GC, 1998, 4 INT C MACR AZ STRE
[8] Effects of rokitamycin on phagocytosis and release of oxidant radicals of human polymorphonuclear leukocytes
Braga, PC
Maci, S
DalSasso, M
Fonti, E
Ghessi, A
[J]. CHEMOTHERAPY, 1997, 43 (03) : 190 - 197
[9] Bryskier A, 1997, Expert Opin Investig Drugs, V6, P1697, DOI 10.1517/13543784.6.11.1697
[10] COSENTINI R, 1998, 4 INT C MACR AZ STRE

← 1 2 3 4 5 →